NEKTAR THERAPEUTICS

Lobbying Spend

—

Filings

Firms Hired

Active Period

2008–2022

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2022	—	2	1
2021	—	4	1
2020	—	6	3
2019	—	10	3
2018	—	8	2
2017	—	7	3
2016	—	4	1
2015	—	4	1
2014	—	4	1
2008	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
QGA PUBLIC AFFAIRS (FORMERLY QUINN GILLESPIE & ASSOCIATES)	—	13
BGR GOVERNMENT AFFAIRS	—	12
MERCURY PUBLIC AFFAIRS LLC	—	12
MANATT, PHELPS, AND PHILLIPS	—	12
CAPITOL ASSOCIATES, INC.	—	3

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	45
SENATE	45
Food & Drug Administration (FDA)	11
Centers For Disease Control & Prevention (CDC)	2
Commerce, Dept of (DOC)	2
Defense, Dept of (DOD)	2
Natl Institutes of Health (NIH)	2
U.S. Trade Representative (USTR)	2
White House Office	2

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	27
Pharmacy	Pharmacy	25
Homeland Security	Homeland Security	1
Chemicals/Chemical Industry	Chemicals/Chemical Industry	1

NEKTAR THERAPEUTICS — Lobbying Disclosure | Poliscope